X-Therma has filed a notice of an exempt offering of securities to raise $22,378,696.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, X-Therma is raising up to $22,378,696.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Xiaoxi Wei played a key role in securing the recent investment.
About X-Therma
X-Therma Inc. is solving unmet legacy needs in the storage of biological products using convergent biomimetic nanotechnology. This solution can better enable critical biomanufacture processes, safer transport and long-term biobanking for advanced cell therapies, in vitro fertilization, organ transplants, and other rapidly growing regenerative medicine areas. X-Therma aims to advance the field of regenerative medicine by making available safe and reliable organs, engineered tissues, and cell therapies to patients in need via a convergent biopreservation platform.
To learn more about X-Therma, visit http://x-therma.com/
Contact:
Xiaoxi Wei, Chief Executive Officer
860-833-7144
https://www.linkedin.com/in/xiaoxi-sofie-wei-0b629032/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.